latest news releases from the newsroom
Investor: Employee Stock Option Program for 2003
STOCKHOLM, Sweden, Feb. 14, 2003 (PRIMEZONE) -- The Board of Directors of Investor AB (Other OTC:IVSBF) has decided on the company's employee stock option program for 2003. The program, which covers all employees, is based on the same structure as the employee stock option programs that have existed for all personnel since 2000 (see Investor's Annual Report for 2001). Investor strives to offer compensation in line with market conditions that makes it possible to recruit senior executives and other employees and keep them in the company. Employee compensation is adapted to Investor's underlying operations and normally consists of fixed salary, variable salary, variable long-term incentive programs (including the employee stock option program) and a pension (which for senior executives consists mainly of a defined-contribution pension plan).
Crucell Signs PER.C6 License with Targeted Genetics
LEIDEN, The Netherlands, Feb. 14, 2003 (PRIMEZONE) -- Crucell N.V. (Nasdaq:CRXL) announced today that it has signed a non-exclusive PER.C6(TM) license agreement with Seattle-based Targeted Genetics Corporation (Nasdaq:TGEN). Targeted Genetics will evaluate and use PER.C6(TM) for research and development in the field of vaccines and has also received an option for a non-exclusive license to commercialize the resulting vaccines.